RSV Vaccine for Adults, Abrysvo, Gets FDA Approval
Pfizer’s vaccine, the second to get FDA approval for RSV, is more than 85 percent effective at preventing severe disease caused by the common respiratory syncytial virus.
Stay updated with breaking news from Beth Thielen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Pfizer’s vaccine, the second to get FDA approval for RSV, is more than 85 percent effective at preventing severe disease caused by the common respiratory syncytial virus.
With 2023 a matter of hours away, there’s a new approach in coping with COVID in Minnesota.
Doctors give advice on when to identify the viral or bacterial infection at work in your illness.
Vaccines now allow your body to ramp up the fight against cold weather bugs as holiday gatherings loom. The shots also help protect hospital capacity, a critical consideration when workforce shortages are already straining health care systems in Minnesota and elsewhere.
Influenza, COVID and RSV are making the rounds, and shots are available for flu and COVID.